H.C. Wainwright analyst Ram Selvaraju reiterated a Hold rating on Inovio Pharmaceuticals (INO - Research Report) today. The company's shares closed yesterday at $2.10.According to TipRanks, Selvaraju is an analyst with an average return of -34.4% and a 19.35% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Regulus, Aeterna Zentaris, and Oncternal Therapeutics.Currently, the analyst consensus on Inovio Pharmaceuticals is a Hold with an average price target of $2.67.See today’s best-performing stocks on TipRanks >>The company has a one-year high of $9.96 and a one-year low of $1.38. Currently, Inovio Pharmaceuticals has an average volume of 7.12M.
https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-hold-on-inovio-pharmaceuticals-ino?utm_source=advfn.com&utm_medium=referral
Inovio Pharmaceuticals (NASDAQ:INO)
Historical Stock Chart
From Oct 2022 to Nov 2022 Click Here for more Inovio Pharmaceuticals Charts.
Inovio Pharmaceuticals (NASDAQ:INO)
Historical Stock Chart
From Nov 2021 to Nov 2022 Click Here for more Inovio Pharmaceuticals Charts.